GE Healthcare beats fourth-quarter earnings estimates to offset soft profit guidance



GE HealthCare Technologies Inc.’s stock rose 1.9% early Tuesday, after the company posted better-than-expected profit and revenue for the fourth quarter, offsetting soft profit guidance for 2024.

GE HealthCare
GEHC,
-0.68%,
which was spun out of General Electric Co.
GE,
+0.86%
in January of 2023 and houses its medical device business, posted net income of $403 million, or 88 cents a share, for the quarter, down from $554 million, or $1.21 a share, in the year-earlier period.

Adjusted per-share earnings came to $1.18, ahead of the $1.07 FactSet consensus.

Revenue rose 5% to $5.2 billion, also ahead of the $5.1 billion FactSet consensus.

Chief Executive Peter Arduini said the company invested more than $1 billion in R&D in its first year of operation as a stand-alone company and made strategic acquisitions to bolster growth, while also paying down $1 billion in debt.

“We’re confident heading into 2024 amid the backdrop of an improved capital equipment landscape,” Arduini said in a statement.

By segment, imaging revenue rose 4% to $2.8 billion, while ultrasound revenue fell 1% to $944 million.

Patient care solutions revenue rose 5% to $827 million, and pharmaceutical diagnostics revenue rose 25% to $591 million.

The company is now expecting 2024 adjusted EPS of $4.20 to $4.35, while FactSet is expecting $5.74.

It expects organic revenue growth, which excludes the impact of foreign exchange and acquisitions. of about 4%. Free cash flow is expected to total $1.8 billion, while FactSet is expecting $2.2 billion.

In other news, GE HealthCare is participating in a project to pioneer an AI-screening platform for early detection of Alzheimer’s disease. It also announced new data validating AI models for predicting patient response to immunotherapies.

The stock has gained 2% in the last 12 months, while the S&P 500
SPX,
-0.32%
has gained 20%.



Source link

About The Author

Scroll to Top